{
    "relation": [
        [
            "Feature key",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti"
        ],
        [
            "Position(s)",
            "7 \u2013 7",
            "15 \u2013 15",
            "16 \u2013 16",
            "19 \u2013 19",
            "21 \u2013 21",
            "22 \u2013 22",
            "25 \u2013 25",
            "45 \u2013 45",
            "51 \u2013 51",
            "59 \u2013 59",
            "63 \u2013 63",
            "69 \u2013 69",
            "74 \u2013 74",
            "77 \u2013 77",
            "114 \u2013 114",
            "114 \u2013 114",
            "118 \u2013 118",
            "119 \u2013 119",
            "124 \u2013 124",
            "126 \u2013 126",
            "127 \u2013 127",
            "133 \u2013 133",
            "135 \u2013 135",
            "142 \u2013 142",
            "144 \u2013 144",
            "161 \u2013 161",
            "178 \u2013 178",
            "183 \u2013 183",
            "187 \u2013 187",
            "188 \u2013 188",
            "189 \u2013 189",
            "190 \u2013 190",
            "191 \u2013 191",
            "192 \u2013 192",
            "192 \u2013 192",
            "194 \u2013 194",
            "205 \u2013 205",
            "216 \u2013 216",
            "219 \u2013 219",
            "226 \u2013 226",
            "236 \u2013 236",
            "248 \u2013 248",
            "275 \u2013 275",
            "279 \u2013 279",
            "279 \u2013 279",
            "281 \u2013 281",
            "283 \u2013 283",
            "286 \u2013 286",
            "291 \u2013 291",
            "294 \u2013 294",
            "299 \u2013 299",
            "305 \u2013 305",
            "320 \u2013 320",
            "322 \u2013 322",
            "323 \u2013 323"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "L \u2192 P in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "K \u2192 I in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "D \u2192 A. Corresponds to variant rs17052019 [ dbSNP | Ensembl ].",
            "N \u2192 S in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "E \u2192 Q in TOF and ASD7. 3 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.10 \"NKX2.5 mutations in patients with tetralogy of fallot.\" Goldmuntz E., Geiger E., Benson D.W. Circulation 104:2565-2568(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS TOF GLN-21; CYS-25; CYS-216 AND VAL-219. Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "Q \u2192 P in ASD7 and TOF. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "R \u2192 C in ASD7; TOF; CHNG5; HLHS2 and CTHM; unknown pathological significance; found in healthy controls; exhibits significant functional impairment with reduction of transactivation properties and dominant-negative effect; the mutant protein activity on the DIO2, TG and TPO promoters is significantly impaired. 7 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.\" Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S., Seidman J.G., Seidman C.E., Plowden J., Kugler J.D. J. Clin. Invest. 104:1567-1573(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT TOF CYS-25, VARIANTS ASD7 LYS-188; GLY-189 AND CYS-191. Ref.10 \"NKX2.5 mutations in patients with tetralogy of fallot.\" Goldmuntz E., Geiger E., Benson D.W. Circulation 104:2565-2568(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS TOF GLN-21; CYS-25; CYS-216 AND VAL-219. Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25. Ref.14 \"Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis.\" Dentice M., Cordeddu V., Rosica A., Ferrara A.M., Santarpia L., Salvatore D., Chiovato L., Perri A., Moschini L., Fazzini C., Olivieri A., Costa P., Stoppioni V., Baserga M., De Felice M., Sorcini M., Fenzi G., Di Lauro R., Tartaglia M., Macchia P.E. J. Clin. Endocrinol. Metab. 91:1428-1433(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161, CHARACTERIZATION OF VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161. Ref.15 \"The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart anomalies: mutation or polymorphism?\" Akcaboy M.I., Cengiz F.B., Inceoglu B., Ucar T., Atalay S., Tutar E., Tekin M. Pediatr. Cardiol. 29:126-129(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT CTHM CYS-25. Corresponds to variant rs28936670 [ dbSNP | Ensembl ].",
            "S \u2192 P in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "F \u2192 L in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "P \u2192 A in VSD3; significantly reduced activation of NPPA gene compared to wild-type. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.17 \"A novel NKX2-5 mutation in familial ventricular septal defect.\" Wang J., Xin Y.F., Liu X.Y., Liu Z.M., Wang X.Z., Yang Y.Q. Int. J. Mol. Med. 27:369-375(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VSD3 ALA-59, CHARACTERIZATION OF VARIANT VSD3 ALA-59.",
            "A \u2192 V in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "L \u2192 P in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "G \u2192 D.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), VARIANT ASP-74. Corresponds to variant rs201362118 [ dbSNP | Ensembl ].",
            "P \u2192 L in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "C \u2192 R in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "C \u2192 S in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "K \u2192 R in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "A \u2192 S in CHNG5; exhibits a significant functional impairment with reduction of transactivation properties and dominant-negative effect which was associated with reduced DNA binding. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.14 \"Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis.\" Dentice M., Cordeddu V., Rosica A., Ferrara A.M., Santarpia L., Salvatore D., Chiovato L., Perri A., Moschini L., Fazzini C., Olivieri A., Costa P., Stoppioni V., Baserga M., De Felice M., Sorcini M., Fenzi G., Di Lauro R., Tartaglia M., Macchia P.E. J. Clin. Endocrinol. Metab. 91:1428-1433(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161, CHARACTERIZATION OF VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161.",
            "K \u2192 R in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "E \u2192 V in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "A \u2192 E in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "P \u2192 S in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "A \u2192 T in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "R \u2192 C in ASD7. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "L \u2192 P in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "R \u2192 P in CHNG5; exhibits a significant functional impairment with reduction of transactivation properties and dominant-negative effect which was associated with reduced DNA binding. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.14 \"Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis.\" Dentice M., Cordeddu V., Rosica A., Ferrara A.M., Santarpia L., Salvatore D., Chiovato L., Perri A., Moschini L., Fazzini C., Olivieri A., Costa P., Stoppioni V., Baserga M., De Felice M., Sorcini M., Fenzi G., Di Lauro R., Tartaglia M., Macchia P.E. J. Clin. Endocrinol. Metab. 91:1428-1433(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161, CHARACTERIZATION OF VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161.",
            "T \u2192 M in ASD7. 3 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.8 \"Congenital heart disease caused by mutations in the transcription factor NKX2-5.\" Schott J.-J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., Maron B.J., Seidman C.E., Seidman J.G. Science 281:108-111(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ASD7 MET-178. Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "K \u2192 E in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "Q \u2192 H in ASD7. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "N \u2192 K in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.\" Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S., Seidman J.G., Seidman C.E., Plowden J., Kugler J.D. J. Clin. Invest. 104:1567-1573(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT TOF CYS-25, VARIANTS ASD7 LYS-188; GLY-189 AND CYS-191. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "R \u2192 G in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.\" Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S., Seidman J.G., Seidman C.E., Plowden J., Kugler J.D. J. Clin. Invest. 104:1567-1573(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT TOF CYS-25, VARIANTS ASD7 LYS-188; GLY-189 AND CYS-191. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "R \u2192 C in ASD7. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "Y \u2192 C in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.9 \"Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.\" Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S., Seidman J.G., Seidman C.E., Plowden J., Kugler J.D. J. Clin. Invest. 104:1567-1573(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT TOF CYS-25, VARIANTS ASD7 LYS-188; GLY-189 AND CYS-191. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "K \u2192 R in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "K \u2192 T in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "K \u2192 R in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "V \u2192 E in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "R \u2192 C in TOF and ASD7. 3 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.10 \"NKX2.5 mutations in patients with tetralogy of fallot.\" Goldmuntz E., Geiger E., Benson D.W. Circulation 104:2565-2568(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS TOF GLN-21; CYS-25; CYS-216 AND VAL-219. Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "A \u2192 V in ASD7 and TOF; somatic mutation. 4 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.10 \"NKX2.5 mutations in patients with tetralogy of fallot.\" Goldmuntz E., Geiger E., Benson D.W. Circulation 104:2565-2568(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS TOF GLN-21; CYS-25; CYS-216 AND VAL-219. Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "D \u2192 N in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "P \u2192 H in ICAS; does not affect DNA binding; impairs transactivation activity. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.7 \"Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.\" Koss M., Bolze A., Brendolan A., Saggese M., Capellini T.D., Bojilova E., Boisson B., Prall O.W., Elliott D.A., Solloway M., Lenti E., Hidaka C., Chang C.P., Mahlaoui N., Harvey R.P., Casanova J.L., Selleri L. Dev. Cell 22:913-926(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, VARIANT ICAS HIS-236, CHARACTERIZATION OF VARIANT ICAS HIS-236.",
            "Y \u2192 H in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "P \u2192 T in ASD7. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25.",
            "S \u2192 F in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "S \u2192 P in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "A \u2192 V in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "P \u2192 Q in VSD3. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.16 \"Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease.\" Peng T., Wang L., Zhou S.F., Li X. Genetica 138:1231-1240(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VSD3 GLN-283.",
            "A \u2192 V in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "Missing in CTMH. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL.",
            "N \u2192 H in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "D \u2192 G in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "S \u2192 G in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "G \u2192 S in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "R \u2192 Q in ASD7; somatic mutation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.12 \"Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.\" Reamon-Buettner S.M., Borlak J. J. Med. Genet. 41:684-690(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77; SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135; PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205; VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286; HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.",
            "A \u2192 T in ASD7 and TOF. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.11 \"NKX2.5 mutations in patients with congenital heart disease.\" McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E. J. Am. Coll. Cardiol. 42:1650-1655(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH ASN-291 DEL. Ref.13 \"Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.\" Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M., Matsuoka R. Am. J. Med. Genet. A 135:47-52(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127; CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191; CYS-216; VAL-219; THR-275 AND THR-323, VARIANT HLHS2 CYS-25."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VAR_038212",
            "VAR_038213",
            "VAR_049581",
            "VAR_038214",
            "VAR_038215",
            "VAR_038216",
            "VAR_010116",
            "VAR_038217",
            "VAR_038218",
            "VAR_067586",
            "VAR_038219",
            "VAR_038220",
            "VAR_069058",
            "VAR_038221",
            "VAR_038222",
            "VAR_038223",
            "VAR_038224",
            "VAR_047869",
            "VAR_038225",
            "VAR_038226",
            "VAR_038227",
            "VAR_038228",
            "VAR_038229",
            "VAR_038230",
            "VAR_038231",
            "VAR_047870",
            "VAR_003752",
            "VAR_038232",
            "VAR_038233",
            "VAR_010117",
            "VAR_010118",
            "VAR_038234",
            "VAR_010119",
            "VAR_038235",
            "VAR_038236",
            "VAR_038237",
            "VAR_038238",
            "VAR_038239",
            "VAR_038240",
            "VAR_038241",
            "VAR_069590",
            "VAR_038242",
            "VAR_038243",
            "VAR_038244",
            "VAR_038245",
            "VAR_038246",
            "VAR_067587",
            "VAR_038247",
            "VAR_067588",
            "VAR_038248",
            "VAR_038249",
            "VAR_038250",
            "VAR_038251",
            "VAR_038252",
            "VAR_038253"
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "NKX2-5 - Homeobox protein Nkx-2.5 - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P52952",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042981460.12/warc/CC-MAIN-20150728002301-00205-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 804253827,
    "recordOffset": 804179598,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Natural variant BLASTProtParamProtScaleCompute pI/MWPeptideMassPeptideCutterGO <p>The checksum is a form of redundancy check that is calculated from the sequence. It is useful for tracking sequence updates.</p> <p>It should be noted that while, in theory, two different sequences could have the same checksum value, the likelihood that this would happen is extremely low.</p> <p>However UniProtKB may contain entries with identical sequences in case of multiple genes (paralogs).</p> <p>The checksum is computed as the sequence 64-bit Cyclic Redundancy Check value (CRC64) using the generator polynomial: x<sup>64</sup> + x<sup>4</sup> + x<sup>3</sup> + x + 1. The algorithm is described in the ISO 3309 standard. </p> <p class=\"publication\">Press W.H., Flannery B.P., Teukolsky S.A. and Vetterling W.T.<br /> <strong>Cyclic redundancy and other checksums</strong><br /> <a href=\"http://www.nrbook.com/b/bookcpdf.php\">Numerical recipes in C 2nd ed., pp896-902, Cambridge University Press (1993)</a>)</p> Checksum:i1DED387CB9297E28 11,681 Mass (Da): 112 Length: Show \u00bb No experimental confirmation available. Note:  10 20 30 40 50 MFPSPALTPT PFSVKDILNL EQQQRSLAAA GELSARLEAT LAPSSCMLAA  60 70 80 90 100 FKPEAYAGPE AAAPGLPELR AELGRAPSPA KCASAFPAAP AFYPRAYSDP  110 DPAKDPRAEK KA \u00ab Hide The",
    "textAfterTable": "Alternative sequence Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.</p><p><a href='../manual/var_seq' target='_top'>More...</a></p>Alternative sequencei 112\u00a0\u2013\u00a0151 40 ELCAL\u2026QAQVY \u2192 GCELPRGQRPPVLFSSALSQ PDFLQMLSETCRWLPVHLAE in isoform 2. 1 Publication <p>Manually curated information that is based on statements in scientific articles for which there is no experimental support.</p> <p><a href=\"/manual/evidences#ECO:0000303\">More\u2026</a></p> Manual assertion based on opinion ini Ref.3 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}